WCN24-1863 Towards an IgA Nephropathy Atlas

WCN24-1863 Towards an IgA Nephropathy Atlas

Saved in:

Bibliographic Details
Main Authors:	Julio Saez-Rodriguez, Jon Barratt, Haresh Selvaskandan, Raphael Duivenvoorden, Matthias Kretzler, Laura Mariani, Celine Berthier, Anna Witsap, Hannes Olauson, Annika Wernerson, Loreto Gesualdo, Jenny Nyström
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924004522
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Novel Treatment Paradigms: Primary IgA Nephropathy
by: Haresh Selvaskandan, et al.
Published: (2024-02-01)

Effect of Telitacicept on Circulating Gd-IgA1 and IgA-Containing Immune Complexes in IgA Nephropathy
by: Jincan Zan, et al.
Published: (2024-04-01)

WCN25-3817 LOIN PAIN IN RARE KIDNEY DISEASE: ANALYSIS OF 3867 QUESTIONNAIRE RESPONSES WITH LINKED DATA FROM THE UK NATIONAL REGISTRY OF RARE KIDNEY DISEASES (RaDaR)
by: Katie Wong, et al.
Published: (2025-02-01)

Constantino P. Kavafis (1863-1933)
by: Constantino P. Kavafis, et al.
Published: (1970-01-01)

Relationship between Gd-IgA1 and TNFR1 in IgA nephropathy and IgA vasculitis nephritis in children – multicenter study
by: Małgorzata Mizerska-Wasiak, et al.
Published: (2021-08-01)

Serum Cytokine Profile in IgA Nephropathy
by: Friederike Selbach, MD, et al.
Published: (2025-02-01)

WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
by: Jonathan Barratt, et al.
Published: (2025-02-01)

Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review.
by: Qiang Sun, et al.
Published: (2016-01-01)

Carboxymethyl-lysine is a Prominent Target of Circulating IgA in IgA Nephropathy
by: Sara Alibrandi, et al.
Published: (2025-07-01)

Aberrantly Glycosylated IgA1 as a Factor in the Pathogenesis of IgA Nephropathy
by: Mototsugu Tanaka, et al.
Published: (2011-01-01)

Comunicación científica e innovación tecnológica en la primera Cruz Roja, 1863-1876
by: Juan Carlos García-Reyes, et al.

The Prevalence and Characteristics of IgA Antibodies to β2-Spectrin and CBX3 in Immunoglobulin A Nephropathy
by: Ayako Koizumi, et al.
Published: (2025-05-01)

Polski teatr w Czerniowcach 1863–1865
by: Alicja Kędziora
Published: (2024-11-01)

IgA Nephropathy in the Elderly
by: Dana V. Rizk, et al.
Published: (2025-08-01)

Significance of serum IgA/C3 ratio in the diagnosis and prognosis of IgA nephropathy
by: XIE Wei-ji, et al.
Published: (2019-01-01)

WCN25-1664 Epidemiology, disease burden and treatment patterns for primary IgA nephropathy patients: A real-world data study in The Netherlands
by: Thom Lysen, et al.
Published: (2025-02-01)

WCN25-844 FELZARTAMAB FOR IgA NEPHROPATHY: FINAL RESULTS OF THE IGNAZ STUDY
by: Uptal Patel, et al.
Published: (2025-02-01)

WCN25-778 AFFINITY study: 1-year results of atrasentan in IgA nephropathy (IgAN)
by: Jonathan Barratt, et al.
Published: (2025-02-01)

Serum IgA/C3 ratio as a diagnostic and prognostic biomarker for IgA nephropathy
by: Anitha Swamy, et al.
Published: (2025-08-01)

Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease
by: Colin Reily, et al.
Published: (2014-01-01)

Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy
by: Hitoshi Irabu, et al.
Published: (2020-01-01)

Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
by: M. Colleen Hastings, et al.
Published: (2012-01-01)

Serial Galactose-Deficient IgA1 Levels in Children with IgA Nephropathy and Healthy Controls
by: John T. Sanders, et al.
Published: (2017-01-01)

Is Childhood IgA Nephropathy Different From Adult IgA Nephropathy? A Narrative Review
by: Areefa Alladin-Karan, et al.
Published: (2025-03-01)

IgA Nephropathy Associated with IgA Vasculitis Coexisting with Focal Segmental Glomerulosclerosis Tip Variant
by: Zitlali Guadalupe Paulín Zepeda, et al.
Published: (2023-07-01)

WCN24-1197 EFFICACY AND SAFETY OF RAVULIZUMAB IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL IN IgA NEPHROPATHY
by: Jonathan Barratt, et al.
Published: (2024-04-01)

On the Genus Eagris Guenée, 1863 in Angola (Lepidoptera: Hesperiidae)
by: A. Bivar de Sousa, et al.
Published: (2007-01-01)

About selective IgA deficiency
by: Sinasi Ozsoylu
Published: (2011-12-01)

Application of hydroxychloroquine for IgA nephropathy
by: Xiao Yong-zhen, et al.
Published: (2021-01-01)

Unconventional T Cells in IgA Nephropathy
by: Zizhang Sheng, et al.
Published: (2025-02-01)

IgA and the gut-vagina axis
by: Kazuhide Takada, et al.
Published: (2025-04-01)

Corrigendum to “Is childhood IgA nephropathy different from adult IgA nephropathy? A narrative review”
Published: (2025-07-01)

IgA Nephropathy and IgA Vasculitis Post-COVID-19 vaccination: A case-based review
by: Arun Prabhahar, et al.
Published: (2022-04-01)

Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts
by: Sean J. Barbour, et al.
Published: (2025-04-01)

IgG subclasses in symptomatic IgA deficiency
by: I Tezcan, et al.
Published: (1992-01-01)

Lysosome-mediated aggregation of galactose-deficient IgA1 with transferrin receptor 1 links to IgA nephropathy
by: Meijun Si, et al.
Published: (2025-07-01)

DNA methylation in Cosmc promoter region and aberrantly glycosylated IgA1 associated with pediatric IgA nephropathy.
by: Qiang Sun, et al.
Published: (2015-01-01)

Clinical and diagnostic significance of isolated detection of IgA antibodies to deamidated gliadin peptides in IgA nephropathy patients
by: M. E. Mantsaeva, et al.
Published: (2025-05-01)

Dynamics of chromatin accessibility governing Gd-IgA1 synthesis in B cells associated with IgA nephropathy
by: Yangang Gan, et al.
Published: (2025-07-01)

An Outline of the History of Poles in Kishinev (1863-1918): Contribution to the Discussion
by: Wojciech Adam Swiech
Published: (2024-06-01)